MS contributes to the development of cardiovascular diseases (CVDs) by changing the lipid profile, increasing inflammation and the activity of inducible nitric oxide synthase (iNOS), thus causing vascular inflammation. The gene discussed is NOS2; the disease is myeloid sarcoma.